RSV subgroup A stabilised prefusion F antigen, RSV subgroup B stabilised prefusion F antigen, Nirsevimab clinical trials

European preparedness platform to treat and prevent respiratory syncytial virus infections in pregnant women and infants

This study looks at new ways to protect babies from a common chest infection called RSV. We're testing if giving a vaccine to pregnant mothers, or an injection to their baby, or both, works best. This helps ensure new medicines are safe and effective for mums and babies.